Overview and Scope
Chemoinformatic refers to an emerging area of information technology that concentrates on the gathering, storing, analyzing, and manipulating of chemical data. It is further used to analyse the association between the target molecular activity, chemical characteristics, and structure.
Sizing and Forecast
The chemoinformatics market size has grown steadily in recent years. It will grow from <b>$4.28 billion in 2023 to $4.4 billion in 2024 at a compound annual growth rate (CAGR) of 2.8%. </b> The growth in the historic period can be attributed to high throughput screening (hts), data availability, drug discovery efficiency, personalized medicine, artificial intelligence (ai) and machine learning.
The chemoinformatics market size is expected to see steady growth in the next few years. It will grow to <b>$4.94 billion in 2028 at a compound annual growth rate (CAGR) of 3.0%. </b> The growth in the forecast period can be attributed to biological data integration, structural biology, data management and security, regulatory compliance, drug discovery efficiency. Major trends in the forecast period include high-throughput screening, structural biology integration, biological data mining, virtual chemical libraries, personalized medicine.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/chemoinformatics-global-market-report
Segmentation & Regional Insights
The chemoinformatics market covered in this report is segmented –
1) By Type: Chemistry, Computer Science, Information Science
2) By Application: Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Other Applications
3) By End User: Chemical and Pharmaceutical Industries, Research and Academic Institution, Other End Users
<b>North America</b> was the largest region in the chemoinformatics market in 2023. <b>Asia-Pacific </b>is expected to be the fastest-growing region in the forecast period. The regions covered in the chemoinformatics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7806&type=smp
Major Driver Impacting Market Growth
The surging prevalence of chronic diseases is expected to propel the growth of the chemoinformatic market going forward. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The rising number of chronic diseases such as neglected tropical diseases demands the need for new drug discoveries and the search for novel chemicals for their treatment, for which chemoinformatic is used. For instance, according to the World Health Organization, a Switzerland-based organization for international public health, between 2020 and 2030, 500 million people are expected to develop chronic diseases such as obesity, diabetes, heart diseases, or other noncommunicable diseases (NCDs) due to physical inactivity, if governments globally do no take immediate action to promote exercises. Therefore, the surging prevalence of chronic diseases is driving the demand for the chemoinformatic market.
Key Industry Players
Major companies operating in the chemoinformatics market include <b> ChemAxon Ltd., Jubilant Biosys Inc., BIOVIA, OpenEye Scientific Software Inc., Schrödinger Inc., Advanced Chemistry Development Inc, Scilligence Corporation, Dassault Systemes SE, Chemical Computing Group Inc, Collaborative Drug Discovery Inc., UVJ Technologies, Golden Helix Inc., KNIME.COM Aktiengesellschaft, Simulations Plus Inc., Agilent Technologies Inc., Cambridgesoft Corp., Bio-Rad Laboratories Inc., Molecular Discovery Ltd., Optibrium Ltd., Cresset Group Ltd., Dotmatics Ltd., Genedata AG, Inte:Ligand GmbH, MolPort Inc., PerkinElmer Inc., Cheminformatics LLC, Chemspace, InfoChem GmbH, Molecular Networks GmbH, VLife Sciences Technologies Pvt. Ltd., Xemistry GmbH, Cheminnovation Software Inc. </b>
The chemoinformatics market report table of contents includes:
1. Executive Summary
2.Chemoinformatics Market Characteristics
3.Chemoinformatics Market Trends And Strategies
4.Chemoinformatics Market analysis
5.Chemoinformatics Market Size And Growth
6.Chemoinformatics Segmentation
7.Chemoinformatics Regional And Country Analysis
.
.
.
27.Chemoinformatics Competitive Landscape And Company Profiles
28.Chemoinformatics Key Mergers And Acquisitions
29.Chemoinformatics Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- ChemAxon Ltd.
- Jubilant Biosys Inc.
- BIOVIA
- OpenEye Scientific Software Inc.
- Schrödinger Inc.
- Advanced Chemistry Development Inc
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
This report focuses on top manufacturers in Global Market.The Global Chemoinformatics Market size is expected to value at USD 21.18 billion by 2024.
In addition, rising importance towards development of various drug validation techniques, and integration of potential drug candidates that are developed by combinatorial chemical methods, are expected to stimulate the growth of chemoinformatics market over the forecast period.
Shifting focus towards the effective management of data, gathered during molecular and atomic reactions is anticipated to boost chemoinformatics market demand over the next seven years.
The recent technological advances in computer technology for healthcare sector is estimated to favor the growth of chemoinformatics market in the upcoming years.
The global Chemoinformatics Market size is expected to value at USD 21.18 billion by 2024.
In addition, rising importance towards development of various drug validation techniques, and integration of potential drug candidates that are developed by combinatorial chemical methods, are expected to stimulate the growth of chemoinformatics industry over the forecast period.Shifting focus towards the effective management of data, gathered during molecular and atomic reactions is anticipated to boost market demand for chemoinformatics over the next seven years.
Globally, the chemoinformatics market is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the market.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/chemoinformatics-market/request-sampleThe recent technological advances in computer technology for healthcare sector is estimated to favor the growth of chemoinformatics industry in the upcoming years.
Some of the key contributing factors responsible for sustained market growth of chemoinformatics include surging prevalence of chronic diseases and the corresponding need to invent novel drugs.
Moreover, the rising number of incidences related to chronic diseases acts as a contributing factor for new drug development, which is directly impacting the market growth of the chemoinformatics.The chemoinformatics market is broadly categorized into three major segments based on the application type such as chemical analysis, drug discovery, and drug validation.
The drug discovery is considered as one of the fastest growing segment in the chemoinformatics industry with substantial revenue generation in the last few years.
The growing demand for nucleic acid and protein sequencing due to a reduction in sequencing costs, increasing research initiatives from government and private organizations, and the growing applications of bioinformatics are the major factors driving the growth of the market.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 6.17 billion in 2017, at CAGR of 14.5%.
The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.
* On the other hand, a lack of well-defined standards and common formats for Data Integration may limit market growth to a certain extent.Some of The Major Players In Synthetic Biology Market:1.
Eurofins ScientificGet Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39In this report, the market has been classified based on product & service, applications, sectors, and region.
Based on product and service, the market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services.
The bioinformatics platforms segment is projected to grow at the highest rate during the forecast period.
